GondolaBio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 45

Employees

  • Latest Deal Type
  • Joint Venture

  • Latest Deal Amount
  • $300M

  • Investors
  • 7

GondolaBio General Information

Description

Operator of a clinical-stage biopharmaceutical company intended to develop therapeutics for patients living with genetic diseases. The company aims to leverage biological research to create medicines addressing high unmet needs across multiple therapeutic areas, modalities, and stages, ranging from early discovery to clinical development, enabling the healthcare industry to treat, manage, and address rare genetic conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3160 Porter Drive
  • Suite 250
  • Palo Alto, CA 94304
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 3160 Porter Drive
  • Suite 250
  • Palo Alto, CA 94304
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GondolaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Joint Venture 16-Aug-2024 $300M Completed Clinical Trials - Phase 2
To view GondolaBio’s complete valuation and funding history, request access »

GondolaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GondolaBio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aisling Capital Venture Capital Minority
BridgeBio Pharma Corporation Minority
Cormorant Asset Management PE/Buyout Minority
Frazier Healthcare Partners PE/Buyout Majority
Patient Square Capital PE/Buyout Minority
You’re viewing 5 of 7 investors. Get the full list »

GondolaBio FAQs

  • When was GondolaBio founded?

    GondolaBio was founded in 2024.

  • Where is GondolaBio headquartered?

    GondolaBio is headquartered in Palo Alto, CA.

  • What is the size of GondolaBio?

    GondolaBio has 45 total employees.

  • What industry is GondolaBio in?

    GondolaBio’s primary industry is Drug Discovery.

  • Is GondolaBio a private or public company?

    GondolaBio is a Private company.

  • What is the current valuation of GondolaBio?

    The current valuation of GondolaBio is .

  • What is GondolaBio’s current revenue?

    The current revenue for GondolaBio is .

  • How much funding has GondolaBio raised over time?

    GondolaBio has raised $300M.

  • Who are GondolaBio’s investors?

    Aisling Capital, BridgeBio Pharma, Cormorant Asset Management, Frazier Healthcare Partners, and Patient Square Capital are 5 of 7 investors who have invested in GondolaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process